Literature DB >> 28782599

Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program.

Theresa Hahn1, Pamela Paplham2, Tammy Austin-Ketch3, Yali Zhang4, Jennifer Grimmer4, Michael Burns4, Sophia Balderman4, Maureen Ross4, Philip L McCarthy4.   

Abstract

This study aimed to ascertain unmet needs in autologous and allogeneic hematopoietic cell transplantation (HCT) recipients actively followed in an established long-term survivorship clinic at Roswell Park Cancer Institute from 2006 to 2012. The Survivor Unmet Needs Survey (SUNS) was mailed to 209 eligible patients and returned by 110 (53% participation rate). SUNS includes 89 items covering 5 domains: Emotional Health, Access and Continuity of Care, Relationships, Financial Concerns, and Information. The top 5 specific unmet needs for autologous HCT patients were inability to set future goals/long-term plans, changes in appearance, bad memory/lacking focus, losing confidence in abilities, and paying household or other bills. For allogeneic HCT patients these 5 unmet needs were tied at 21% of respondents: ability to earn money, pay bills, feeling tired, feeling depressed, and dealing with others' expectations of "returning to normal." The top 5 needs reported by females were all from the emotional health domain, whereas males reported financial domain unmet needs. Self-reported participation in health maintenance and screening tests varied greatly from 88% of patients having routine annual bloodwork to 13% of patients having an exercise stress test in the past year. Our findings demonstrate unmet needs in emotional health and financial burden in HCT survivors and variable compliance with survivorship screening.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic; Autologous; Quality of life; Survivorship; Unmet needs

Mesh:

Year:  2017        PMID: 28782599     DOI: 10.1016/j.bbmt.2017.07.024

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  5 in total

1.  Psychosocial and financial issues after hematopoietic cell transplantation.

Authors:  David Buchbinder; Nandita Khera
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review.

Authors:  Catriona Parker; Danielle Berkovic; Darshini Ayton; Ella Zomer; Danny Liew; Andrew Wei
Journal:  Curr Oncol       Date:  2022-05-24       Impact factor: 3.109

3.  Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant.

Authors:  Jessica P Hwang; Sairah Ahmed; Ella J Ariza-Heredia; Zhigang Duan; Hui Zhao; Kathleen M Schmeler; Lois Ramondetta; Susan L Parker; Maria E Suarez-Almazor; Alessandra Ferrajoli; Ya-Chen Tina Shih; Sharon H Giordano; Elizabeth Y Chiao
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-09       Impact factor: 5.742

4.  Incidence and Risk Factors for De Novo Cutaneous Squamous Cell Carcinoma in a Contemporary Cohort of Long-Term Hematopoietic Cell Transplantation Survivors.

Authors:  Jennifer Berano Teh; Farah Abdulla; Kelly Peng; Liezl Atencio; Meagan Echevarria; Aleksi Iukuridze; Alan C Geller; F Lennie Wong; Stephen J Forman; Ryotaro Nakamura; Badri Modi; Saro H Armenian
Journal:  J Invest Dermatol       Date:  2021-02-18       Impact factor: 7.590

5.  Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH).

Authors:  Saro H Armenian; Lanie Lindenfeld; Aleksi Iukuridze; Meagan Echevarria; Samantha Bebel; Catherine Coleman; Ryotaro Nakamura; Farah Abdullah; Badri Modi; Kevin C Oeffinger; Karen M Emmons; Ashfaq A Marghoob; Alan C Geller
Journal:  BMC Cancer       Date:  2020-08-03       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.